Manufacturing Considerations for the Development of Lipid Nanoparticles Using Microfluidics

Carla B Roces1, Gustavo Lou1, Nikita Jain2

  • 1Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow G4 0RE, UK.

Pharmaceutics
|November 18, 2020
PubMed
Summary

Microfluidics enables scalable manufacture of lipid nanoparticles (LNPs) for RNA delivery. Key parameters like flow rate ratio and total flow rate significantly impact LNP size and characteristics, guiding efficient LNP system development.

Related Concept Videos